LEADER 01029nam0 22002891i 450 001 UON00323514 005 20231205104150.371 010 $a20-7038-160-9 100 $a20090511d1955 |0itac50 ba 101 $afre 102 $aFR 105 $a|||| ||||| 200 1 $aˆLes ‰boucs$fDriss Chraibi 210 $a[Paris]$cDenoel$dc1955 215 $a181 p.$d18 cm 410 1$1001UON00067141$12001 $aCollection folio$v2072 606 $aROMANZI MAROCCHINI (lett. francofona)$3UONC019129$2FI 620 $aFR$dParis$3UONL002984 676 $aMAR843$cRACCONTI MAROCCHINI (lett. francofona)$v21 700 1$aCHRAIBI$bDriss$3UONV042824$0443142 712 $aDenoël$3UONV252799$4650 801 $aIT$bSOL$c20240220$gRICA 899 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$2UONSI 912 $aUON00323514 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI B Afr 1 0501 $eSI AA 29758 5 0501 996 $aBoucs$986726 997 $aUNIOR LEADER 02333nam 2200625 a 450 001 9910970359003321 005 20241107101013.0 010 $a0-8389-9200-5 010 $a1-283-09340-5 010 $a9786613093400 010 $a0-8389-9199-8 035 $a(CKB)2560000000071601 035 $a(EBL)675853 035 $a(OCoLC)712047507 035 $a(SSID)ssj0000471297 035 $a(PQKBManifestationID)12159903 035 $a(PQKBTitleCode)TC0000471297 035 $a(PQKBWorkID)10428096 035 $a(PQKB)11359357 035 $a(MiAaPQ)EBC675853 035 $a(Au-PeEL)EBL675853 035 $a(CaPaEBR)ebr10469324 035 $a(CaONFJC)MIL309340 035 $a(ODN)ODN0000585678 035 $a(EXLCZ)992560000000071601 100 $a20100212d2011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aMentoring in the library $ebuilding for the future /$fMarta K. Lee 205 $a1st ed. 210 $aChicago $cAmerican Library Association$d2011 215 $a1 online resource (135 p.) 225 1 $aALA guides for the busy librarian 300 $aDescription based upon print version of record. 311 08$a0-8389-3593-1 320 $aIncludes bibliographical references and index. 327 $aIntroduction to mentoring -- Mentoring internships -- Mentoring and library school assignments -- Should I become a librarian? -- Developing the new librarian in the work place -- Mentoring for promotion -- Volunteers in libraries and librarians as volunteers -- Mentoring librarians electronically -- Other kinds of mentoring in the library field -- Conclusions. 330 $aNoted reference librarian and researcher Lee offers librarians at all levels both her experience and her ideas about establishing a formal mentoring process at the library 410 0$aALA guides for the busy librarian. 606 $aMentoring in library science$zUnited States 615 0$aMentoring in library science 676 $a020.71/55 676 $a020.7155 686 $aLAN025000$2bisacsh 700 $aLee$b Marta K$01819731 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910970359003321 996 $aMentoring in the library$94380225 997 $aUNINA LEADER 03139nam 2200361z- 450 001 9910136403703321 005 20210211 035 $a(CKB)3710000000612060 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/54550 035 $a(oapen)doab54550 035 $a(EXLCZ)993710000000612060 100 $a20202102d2014 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNew anti-infective strategies for treatment of tularemia 210 $cFrontiers Media SA$d2014 215 $a1 online resource (78 p.) 225 1 $aFrontiers Research Topics 311 08$a2-88919-339-X 330 $aFrancisella tularensis, the causative agent of tularemia, is a paradigm among human pathogens. This Gram-negative bacterium has an intracellular lifestyle, which probably reflects an adaptation to its natural animal and protozoa reservoirs. This is one of the most infectious agents in humans and animals; only a few bacteria are needed to induce a severe infection in both types of hosts. The clinical presentation and severity of human tularemia varies according to the portal of entry of bacteria, the bacterial inoculum, the virulence of the infecting strain, and the immune response of the host. Although most infections occur after direct inoculation of bacteria through the skin (through skin wounds or bites of arthropods), pneumonia due to inhalation of infected aerosols is the most feared of the clinical forms of the disease, particularly in the context of biological threat. Two subspecies are responsible for tularemia (subsp. tularensis and subsp. holarctica), and several clades have been described for each, which might be associated with changes in disease severity in humans. Tularemia is also more severe in people with an impaired immune response. No safe vaccine is currently available for prophylaxis of tularemia in humans. On the other hand, control of proliferation of F. tularensis in wildlife is not feasible. Thus, only the anti-infective agents are used for treatment and prophylaxis of human tularemia. The standard options include aminoglycosides (gentamicin), tetracyclines (eg, doxycycline) and fluoroquinolones (eg, ciprofloxacin). The selection of acquired resistance to these antibiotics in F. tularensis, especially in the context of a biological threat, may quickly limit the therapeutic options. New prophylactic and therapeutic alternatives must be developed rapidly. The present Research Topic focuses on potential new strategies for treatment of tularemia, including the development and evaluation of new compounds having proper antibacterial activity, reducing the virulence of F. tularensis or enhancing the immune host response. 610 $aantiinfective agents 610 $aFrancisella tularensis 610 $aimmunomodulators 610 $aTularemia 610 $aVirulence 700 $aMax Maurin$4auth$01287805 906 $aBOOK 912 $a9910136403703321 996 $aNew anti-infective strategies for treatment of tularemia$93020428 997 $aUNINA